Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells

Georgette D Kanmogne1, Sangya Singh1, Upal Roy1, Xinming Liu1, JoEllyn McMillan1, Santhi Gorantla1, Shantanu Balkundi1, Nathan Smith1, Yazen Alnouti2, Nagsen Gautam2, You Zhou3, Larisa Poluektova1, Alexander Kabanov2, Tatiana Bronich2, Howard E Gendelman11Departments of Pharmacology and Experimental...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kanmogne GD, Singh S, Roy U, Liu X, McMillan J, Gorantla S, Balkundi S, Smith N, Alnouti Y, Gautam N, Zhou Y, Poluektova L, Kabanov A, Bronich T, Gendelman HE
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://doaj.org/article/2a99a17a8bab45da873bc130440f710f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2a99a17a8bab45da873bc130440f710f
record_format dspace
spelling oai:doaj.org-article:2a99a17a8bab45da873bc130440f710f2021-12-02T05:55:47ZMononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells1176-91141178-2013https://doaj.org/article/2a99a17a8bab45da873bc130440f710f2012-05-01T00:00:00Zhttp://www.dovepress.com/mononuclear-phagocyte-intercellular-crosstalk-facilitates-transmission-a9851https://doaj.org/toc/1176-9114https://doaj.org/toc/1178-2013Georgette D Kanmogne1, Sangya Singh1, Upal Roy1, Xinming Liu1, JoEllyn McMillan1, Santhi Gorantla1, Shantanu Balkundi1, Nathan Smith1, Yazen Alnouti2, Nagsen Gautam2, You Zhou3, Larisa Poluektova1, Alexander Kabanov2, Tatiana Bronich2, Howard E Gendelman11Departments of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, 2Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE; 3Center for Biotechnology, University of Nebraska-Lincoln, Lincoln, NE, USAAbstract: Despite the successes of antiretroviral therapy (ART), HIV-associated neurocognitive disorders remain prevalent in infected people. This is due, in part, to incomplete ART penetration across the blood–brain barrier (BBB) and lymph nodes and to the establishment of viral sanctuaries within the central nervous system. In efforts to improve ART delivery, our laboratories developed a macrophage-carriage system for nanoformulated crystalline ART (nanoART) (atazanavir, ritonavir, indinavir, and efavirenz). We demonstrate that nanoART transfer from mononuclear phagocytes (MP) to human brain microvascular endothelial cells (HBMEC) can be realized through cell-to-cell contacts, which can facilitate drug passage across the BBB. Coculturing of donor MP containing nanoART with recipient HBMEC facilitates intercellular particle transfer. NanoART uptake was observed in up to 52% of HBMEC with limited cytotoxicity. Folate coating of nanoART increased MP to HBMEC particle transfer by up to 77%. To translate the cell assays into relevant animal models of disease, ritonavir and atazanavir nanoformulations were injected into HIV-1-infected NOD/scid-γcnull mice reconstituted with human peripheral blood lymphocytes. Atazanavir and ritonavir levels in brains of mice treated with folate-coated nanoART were three- to four-fold higher than in mice treated with noncoated particles. This was associated with decreased viral load in the spleen and brain, and diminished brain CD11b-associated glial activation. We postulate that monocyte-macrophage transfer of nanoART to brain endothelial cells could facilitate drug entry into the brain.Keywords: nanoART, folate, monocyte-endothelial cell interactions, blood–brain barrier, antiretroviral therapy, nanomedicineKanmogne GDSingh SRoy ULiu XMcMillan JGorantla SBalkundi SSmith NAlnouti YGautam NZhou YPoluektova LKabanov ABronich TGendelman HEDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2012, Iss default, Pp 2373-2388 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Kanmogne GD
Singh S
Roy U
Liu X
McMillan J
Gorantla S
Balkundi S
Smith N
Alnouti Y
Gautam N
Zhou Y
Poluektova L
Kabanov A
Bronich T
Gendelman HE
Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells
description Georgette D Kanmogne1, Sangya Singh1, Upal Roy1, Xinming Liu1, JoEllyn McMillan1, Santhi Gorantla1, Shantanu Balkundi1, Nathan Smith1, Yazen Alnouti2, Nagsen Gautam2, You Zhou3, Larisa Poluektova1, Alexander Kabanov2, Tatiana Bronich2, Howard E Gendelman11Departments of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, 2Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE; 3Center for Biotechnology, University of Nebraska-Lincoln, Lincoln, NE, USAAbstract: Despite the successes of antiretroviral therapy (ART), HIV-associated neurocognitive disorders remain prevalent in infected people. This is due, in part, to incomplete ART penetration across the blood–brain barrier (BBB) and lymph nodes and to the establishment of viral sanctuaries within the central nervous system. In efforts to improve ART delivery, our laboratories developed a macrophage-carriage system for nanoformulated crystalline ART (nanoART) (atazanavir, ritonavir, indinavir, and efavirenz). We demonstrate that nanoART transfer from mononuclear phagocytes (MP) to human brain microvascular endothelial cells (HBMEC) can be realized through cell-to-cell contacts, which can facilitate drug passage across the BBB. Coculturing of donor MP containing nanoART with recipient HBMEC facilitates intercellular particle transfer. NanoART uptake was observed in up to 52% of HBMEC with limited cytotoxicity. Folate coating of nanoART increased MP to HBMEC particle transfer by up to 77%. To translate the cell assays into relevant animal models of disease, ritonavir and atazanavir nanoformulations were injected into HIV-1-infected NOD/scid-γcnull mice reconstituted with human peripheral blood lymphocytes. Atazanavir and ritonavir levels in brains of mice treated with folate-coated nanoART were three- to four-fold higher than in mice treated with noncoated particles. This was associated with decreased viral load in the spleen and brain, and diminished brain CD11b-associated glial activation. We postulate that monocyte-macrophage transfer of nanoART to brain endothelial cells could facilitate drug entry into the brain.Keywords: nanoART, folate, monocyte-endothelial cell interactions, blood–brain barrier, antiretroviral therapy, nanomedicine
format article
author Kanmogne GD
Singh S
Roy U
Liu X
McMillan J
Gorantla S
Balkundi S
Smith N
Alnouti Y
Gautam N
Zhou Y
Poluektova L
Kabanov A
Bronich T
Gendelman HE
author_facet Kanmogne GD
Singh S
Roy U
Liu X
McMillan J
Gorantla S
Balkundi S
Smith N
Alnouti Y
Gautam N
Zhou Y
Poluektova L
Kabanov A
Bronich T
Gendelman HE
author_sort Kanmogne GD
title Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells
title_short Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells
title_full Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells
title_fullStr Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells
title_full_unstemmed Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells
title_sort mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells
publisher Dove Medical Press
publishDate 2012
url https://doaj.org/article/2a99a17a8bab45da873bc130440f710f
work_keys_str_mv AT kanmognegd mononuclearphagocyteintercellularcrosstalkfacilitatestransmissionofcelltargetednanoformulatedantiretroviraldrugstohumanbrainendothelialcells
AT singhs mononuclearphagocyteintercellularcrosstalkfacilitatestransmissionofcelltargetednanoformulatedantiretroviraldrugstohumanbrainendothelialcells
AT royu mononuclearphagocyteintercellularcrosstalkfacilitatestransmissionofcelltargetednanoformulatedantiretroviraldrugstohumanbrainendothelialcells
AT liux mononuclearphagocyteintercellularcrosstalkfacilitatestransmissionofcelltargetednanoformulatedantiretroviraldrugstohumanbrainendothelialcells
AT mcmillanj mononuclearphagocyteintercellularcrosstalkfacilitatestransmissionofcelltargetednanoformulatedantiretroviraldrugstohumanbrainendothelialcells
AT gorantlas mononuclearphagocyteintercellularcrosstalkfacilitatestransmissionofcelltargetednanoformulatedantiretroviraldrugstohumanbrainendothelialcells
AT balkundis mononuclearphagocyteintercellularcrosstalkfacilitatestransmissionofcelltargetednanoformulatedantiretroviraldrugstohumanbrainendothelialcells
AT smithn mononuclearphagocyteintercellularcrosstalkfacilitatestransmissionofcelltargetednanoformulatedantiretroviraldrugstohumanbrainendothelialcells
AT alnoutiy mononuclearphagocyteintercellularcrosstalkfacilitatestransmissionofcelltargetednanoformulatedantiretroviraldrugstohumanbrainendothelialcells
AT gautamn mononuclearphagocyteintercellularcrosstalkfacilitatestransmissionofcelltargetednanoformulatedantiretroviraldrugstohumanbrainendothelialcells
AT zhouy mononuclearphagocyteintercellularcrosstalkfacilitatestransmissionofcelltargetednanoformulatedantiretroviraldrugstohumanbrainendothelialcells
AT poluektoval mononuclearphagocyteintercellularcrosstalkfacilitatestransmissionofcelltargetednanoformulatedantiretroviraldrugstohumanbrainendothelialcells
AT kabanova mononuclearphagocyteintercellularcrosstalkfacilitatestransmissionofcelltargetednanoformulatedantiretroviraldrugstohumanbrainendothelialcells
AT bronicht mononuclearphagocyteintercellularcrosstalkfacilitatestransmissionofcelltargetednanoformulatedantiretroviraldrugstohumanbrainendothelialcells
AT gendelmanhe mononuclearphagocyteintercellularcrosstalkfacilitatestransmissionofcelltargetednanoformulatedantiretroviraldrugstohumanbrainendothelialcells
_version_ 1718400161675214848